Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...

A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health ...

Study claims Ozempic may also help reduce dementia risk By Talker News Jun 25, 2025 Updated Jun 25, 2025 Haberdoedas ...

Dementia New Study: Ozempic May Lower the Risk of Alzheimer’s Diabetes patients taking semaglutide are less likely to develop dementia, research finds. Posted June 30, 2025 | Reviewed by Devon Frye ...